Comprehensive transcriptomic analysis shows disturbed calcium homeostasis and deregulation of T lymphocyte apoptosis in inclusion body myositis
Mridul JohariiD, Anna ViholaiD, Johanna PalmioiD, Manu E. JokelaiD, Per Harald JonsoniD, Jaakko SarparantaiD, Sanna HuovineniD, Marco SavareseiD, Peter HackmaniD, Bjarne UddiD
Abstract
ObjectiveInclusion body myositis (IBM) has an unclear molecular etiology due to the co-existence of characteristic cytotoxic T-cell activity and degeneration of muscle fibers. Using in-depth gene expression and splicing studies, we aimed at understanding the different components of the molecular pathomechanisms in IBM. MethodsWe performed RNA-seq on RNA extracted from skeletal muscle biopsies of clinically and histopathologically defined IBM (n=24), tibial muscular dystrophy (n=6), and histopathologically normal group (n=9). In a comprehensive transcriptomics analysis, we analyzed the differential gene expression, differential splicing and exon usage, downstream pathway analysis, and the interplay between coding and non-coding RNAs (micro RNAs and long non-coding RNAs). ResultsWe observe dysregulation of genes involved in calcium homeostasis, particularly affecting the T-cell activity and regulation, causing disturbed Ca2+ induced apoptotic pathway of T cells in IBM muscles. Additionally, LCK/p56, which is an essential gene in regulating the fate of T-cell apoptosis, shows altered expression and splicing usage in IBM muscles InterpretationOur analysis provides a novel understanding of the molecular mechanisms in IBM by showing a detailed dysregulation of genes involved in calcium homeostasis and its effect on T-cell functioning in IBM muscles. Loss of T-cell regulation is hypothesized to be involved in the consistent observation of no response to immune therapies in IBM patients. Our results show that loss of apoptotic control of cytotoxic T cells could indeed be one component of their abnormal cytolytic activity in IBM muscles.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 18
- FWCI
- 3.07
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis
K. A. Britson, J. P. Ling, … T. E. Lloyd·bioRxiv·Apr 9, 2021
- Interferon-gamma mediates skeletal muscle lesions through JAK/STAT pathway activation in inclusion body myositis
C. Hou, B. Periou, … F. J. Authier·bioRxiv·Dec 16, 2021
- Mitochondrial leakage and mtDNA damage trigger early immune response in Inclusion Body Myositis.
Felix Kleefeld, Emily Cross, … Rita Horváth·bioRxiv·Aug 5, 2024
- Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositis
I. Pinal-Fernandez, A. Quintana, … A. L. Mammen·bioRxiv·Dec 12, 2022
- Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositis
B. A. Siddiqui, N. L. Palaskas, … S. K. Subudhi·bioRxiv·Sep 15, 2023
- A combination of major histocompatibility complex (MHC) I overexpression and type I interferon induce mitochondrial dysfunction in human skeletal myoblasts.
Anastasia Thoma, Razan Alomosh, … Adam P. Lightfoot·Journal of Cellular PhysiologyPeer-reviewed·Oct 9, 2024